We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
85 hedge funds and large institutions have $205M invested in State Street SPDR S&P Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
261% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $316K
189% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 9
33% more capital invested
Capital invested by funds: $154M → $205M (+$51M)
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
21% more funds holding
Funds holding: 70 → 85 (+15)
5.93% more ownership
Funds ownership: 45.71% → 51.63% (+5.9%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
85
Holders Change
+15
Holders Change %
+21.43%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
21
Reduced
16
Closed
9
Calls
$1.14M
Puts
$316K
Net Calls
+$825K
Net Calls Change
+$1.35M
Top Buyers
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$15.5M |
| 2 |
Morgan Stanley
New York
|
+$14M |
| 3 |
Lazard Asset Management
New York
|
+$7.35M |
| 4 |
JP Morgan Chase
New York
|
+$5.42M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.05M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.8M |
| 2 |
JGGDR
JGP Global Gestao de Recursos
Rio De Janeiro,
Brazil
|
-$6.45M |
| 3 |
Goldman Sachs
New York
|
-$2.28M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.82M |
| 5 |
VF
Virtu Financial
New York
|
-$1.5M |
